|
1.
|
|
10 p, 3.2 MB |
Association of chronic heart failure with mortality in old intensive care patients suffering from Covid-19
/
Bruno, Raphael Romano (Heinrich Heine University Düsseldorf) ;
Wernly, Bernhard (Paracelsus Medical University Salzburg) ;
Wolff, Georg (Heinrich Heine University Düsseldorf) ;
Fjølner, Jesper (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Bollen Pinto, Bernardo (Geneva University Hospitals) ;
Schefold, Joerg C. (University of Bern) ;
Kindgen-Milles, Detlef (Heinrich Heine University Düsseldorf) ;
Baldia, Philipp Heinrich (Heinrich Heine University Düsseldorf) ;
Kelm, Malte (Medical Faculty of the Heinrich-Heine University) ;
Beil, Michael (Hebrew University of Jerusalem) ;
Sviri, Sigal (Hebrew University of Jerusalem) ;
van Heerden, Peter Vernon (Hebrew University of Jerusalem) ;
Szczeklik, Wojciech (Jagiellonian University Medical College) ;
Topeli, Arzu (Hacettepe University Faculty of Medicine) ;
Elhadi, Muhammed (University of Tripoli) ;
Joannidis, Michael (Medical University Innsbruck) ;
Oeyen, Sandra (Universitair Ziekenhuis Gent) ;
Kondili, Eumorfia (University Hospital of Heraklion) ;
Marsh, Brian (Mater Misericordiae University Hospital(Dublín, Irlanda)) ;
Andersen, Finn H. (Norwegian University of Science and Technology) ;
Moreno, Rui (Nova Medical School) ;
Leaver, Susannah (St George's University Hospitals NHS Foundation Trust) ;
Boumendil, Ariane (Hôpital Saint-Antoine) ;
De Lange, Dylan W. (Utrecht University) ;
Guidet, Bertrand (Hôpital Saint-Antoine) ;
Flaatten, Hans (Haukeland University Hospital (Bergen, Noruega)) ;
Jung, Christian (Heinrich Heine University Düsseldorf) ;
Universitat Autònoma de Barcelona
Chronic heart failure (CHF) is a major risk factor for mortality in coronavirus disease 2019 (COVID-19). This prospective international multicentre study investigates the role of pre-existing CHF on clinical outcomes of critically ill old (≥70 years) intensive care patients with COVID-19. [...]
2022 -  10.1002/ehf2.13854
ESC Heart Failure, Vol. 9 (march 2022) , p. 1756-1765
|
|
|
2.
|
|
13 p, 786.1 KB |
A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
/
Rello, Jordi (Hospital Universitari Vall d'Hebron) ;
Krenn, Claus-Georg (Medical University of Vienna) ;
Locker, Gottfried (Medical University of Vienna) ;
Pilger, Ernst (University Hospital Graz, Graz, Austria) ;
Madl, Christian (Medical University of Vienna) ;
Balica, Laura (Emergency Clinical Hospital Bucharest) ;
Dugernier, Thierry (Clinique St. Pierre, Ottignies, Belgium) ;
Laterre, Pierre-Francois (St. Luc University Hospital UCL, Université Catholique de Louvain, Brussels, Belgium) ;
Spapen, Herbert (University Hospital Vrije Universiteit Brussels, Brussels, Belgium) ;
Depuydt, Pieter (UZ Gent, Gent, Belgium) ;
Vincent, Jean-Louis (Université Libre de Bruxelles) ;
Bogár, Lajos (University of Pécs, Pécs, Hungary) ;
Szabó, Zsuzsanna (Uzsoki Hospital, Budapest, Hungary) ;
Völgyes, Barbara (Bajcsy Zsilinszky Hospital and Polyclinic, Budapest, Hungary) ;
Máñez, Rafael (Hospital Universitari de Bellvitge) ;
Çakar, Nahit (Istanbul University Capa Medical Faculty, Istanbul, Turkey) ;
Ramazanoglu, Atilla (Akdeniz University, Antalya, Turkey) ;
Topeli, Arzu (Hacettepe University Hospital, Ankara, Turkey) ;
Mastruzzo, Maria A. (Hospital Dr. Carlos Bocalandro, Buenos Aires, Argentina) ;
Jasovich, Abel (Sanatorio Güemes, Buenos Aires, Argentina) ;
Remolif, Christian G. (Hospital "Heroes de Malvinas", Buenos Aires, Argentina) ;
del Carmen Soria, Liliana (Hospital Central Mendoza, Ciudad de Mendoza, Argentina) ;
Andresen Hernandez, Max A. (Pontificia Universidad Católica de Chile) ;
Ruiz Balart, Carolina (Hospital Dr. Sótero del Rio, Santiago, Chile) ;
Krémer, Ildikó (Flor Ferenc County Hospital, Kistarcsa, Hungary) ;
Molnár, Zsolt (University of Szeged, Szeged, Hungary) ;
von Sonnenburg, Frank (University of Munich, Germany) ;
Lyons, Arthur (Walter Reed Army Institute of Research) ;
Joannidis, Michael (Medical University of Innsbruck, Innsbruck, Austria) ;
Burgmann, Heinz (Medical University of Vienna) ;
Welte, Tobias (Hannover Medical School, Hannover, Germany) ;
Klingler, Anton (Assign Data Management and Biostatistics GmbH, Innsbruck, Austria) ;
Hochreiter, Romana (Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria) ;
Westritschnig, Kerstin (Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria) ;
Universitat Autònoma de Barcelona
Currently, no vaccine against Pseudomonas is available. IC43 is a new, recombinant, protein (OprF/I)-based vaccine against the opportunistic pathogen, Pseudomonas aeruginosa, a major cause of serious hospital-acquired infections. [...]
2017 - 10.1186/s13054-017-1601-9
Critical Care, Vol. 21 (february 2017)
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
